Results 191 to 200 of about 187,608 (218)

HPV Genotype Distribution in Cervical Cancer and High‐Grade Lesions in Norway, and Early Vaccine Impact

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT All cases of invasive cervical cancer (ICC) and subsets of high‐grade cervical intraepithelial neoplasia grade 2 or 3 (CIN2/3) and adenocarcinoma in situ (AIS) in Norway are tested for 37 human papillomavirus (HPV) genotypes, within a mandatory national surveillance system.
Terese Bekkevold   +13 more
wiley   +1 more source

Enhancing DC cancer vaccine by allogeneic MHC class II expression and Treg depletion. [PDF]

open access: yesJCI Insight
Seishima N   +6 more
europepmc   +1 more source

Lung cancer vaccine strategies: exploring the spectrum from traditional to RNA-based platforms. [PDF]

open access: yesFront Bioeng Biotechnol
Pazoki A   +4 more
europepmc   +1 more source

Balancing Antigen Loading on Gold Nanoparticles: Implications for Future Cancer Vaccine Strategies. [PDF]

open access: yesChemistry
Ghirardello M   +8 more
europepmc   +1 more source

Promising future of breast cancer vaccine asking for multidisciplinary collaboration: a literature review. [PDF]

open access: yesFront Cell Dev Biol
Zhang Z   +8 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Why Young Patients With Cancer Refuse the Human Papillomavirus Vaccine

Ca-A Cancer Journal for Clinicians, 2023
Mike Fillon
exaly  

Clinician Communication Strategies Associated With Increased Uptake of the Human Papillomavirus (HPV) Vaccine: A Systematic Review

Ca-A Cancer Journal for Clinicians, 2022
Joey Nicholson   +2 more
exaly  

Home - About - Disclaimer - Privacy